Abstract
A single-step gateway synthesis of glochidine and its congeners that possess the rare uncommon tetrahydroimidazo[1,5-c]pyrrolo[1,2-a]pyrimidine core was developed employing histamine and readily available γ-ketoesters. Key features of the developed reaction involve tandem three C–N bonds formation and concomitant annulation of two rings in one pot to access this unique and complex tricyclic structure. Exploration of the unknown bioactivity of these compounds revealed that they elicit antiproliferative activity comparable to the anticancer drug imatinib against 6 cancer cell lines.
| Original language | English |
|---|---|
| Article number | 130760 |
| Journal | Tetrahedron |
| Volume | 75 |
| Issue number | 51 |
| DOIs | |
| Publication status | Published - 20 Dec 2019 |
Bibliographical note
Publisher Copyright:© 2019 Elsevier Ltd
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Anticancers
- Cyclization reactions
- Imidazo[1,5-c]pyrrolo[1,2-a]pyrimidines
- N-Acyliminium ions
- Natural products analogs
- Tandem reaction
- Tetrahydroimidazo[1,5-c]pyrrolo[1,2-a]pyrimidin-7(8H)-ones
Fingerprint
Dive into the research topics of 'An expeditious entry to rare tetrahydroimidazo[1,5-c]pyrrolo[1,2-a]pyrimidin-7(8H)-ones: A single-step gateway synthesis of glochidine congeners'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver